1. Home
  2. HUDI vs MBRX Comparison

HUDI vs MBRX Comparison

Compare HUDI & MBRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Huadi International Group Co. Ltd.

HUDI

Huadi International Group Co. Ltd.

HOLD

Current Price

$1.25

Market Cap

17.3M

Sector

Industrials

ML Signal

HOLD

Logo Moleculin Biotech Inc.

MBRX

Moleculin Biotech Inc.

HOLD

Current Price

$7.33

Market Cap

23.5M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
HUDI
MBRX
Founded
1998
2015
Country
China
United States
Employees
N/A
N/A
Industry
Steel/Iron Ore
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
17.3M
23.5M
IPO Year
2021
2016

Fundamental Metrics

Financial Performance
Metric
HUDI
MBRX
Price
$1.25
$7.33
Analyst Decision
Strong Buy
Analyst Count
0
4
Target Price
N/A
$125.00
AVG Volume (30 Days)
13.8K
105.9K
Earning Date
08-06-2025
11-13-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$66,566,370.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.06
$6.01
52 Week High
$5.46
$91.25

Technical Indicators

Market Signals
Indicator
HUDI
MBRX
Relative Strength Index (RSI) 47.67 89.96
Support Level $1.23 $0.26
Resistance Level $1.34 $7.75
Average True Range (ATR) 0.07 0.29
MACD 0.01 0.83
Stochastic Oscillator 60.47 93.19

Price Performance

Historical Comparison
HUDI
MBRX

About HUDI Huadi International Group Co. Ltd.

Huadi International Group Co Ltd is a manufacturer of industrial stainless steel seamless pipes and tubes products. Its products are used in the oil & gas transmission, chemistry engineering, food processing, medical devices, aeronautics and astronautics, boiler, irrigation works construction, automobile and naval architecture, paper mill and mechanical industries. Company generates revenue from Sales of steel piping products. Products are exported to the United States, Mexico, Thailand, Singapore, Argentina, Taiwan, India, the Philippines, UAE and Canada. Geographically, majority revenue is generated from China.

About MBRX Moleculin Biotech Inc.

Moleculin Biotech Inc is a clinical stage pharmaceutical company focused on the development of a broad portfolio of drug candidates for the treatment of resistant tumors and viruses. The company's Annamycin program is a next-generation anthracycline designed to avoid multidrug resistance mechanisms with little to no cardiotoxicity.

Share on Social Networks: